Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MedVoima Oy
OY
Dissolved
Y-tunnus 3126142-2
Sepelkyyhkyntie 3-C27
General medical practice activities · NACE 8621
Est. 2020
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 0
EBITDA margin
—
-374% vs 2021
Equity ratio
84.7%
Financial strength
Net profit 2024
EUR -21K
-449% vs 2021
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 0
—
EBITDA
EUR -21K
-374%
Net profit
EUR -21K
-449%
Total assets
EUR 9K
-42%
Equity
EUR 8K
+32%
Employees
—
—
Company information
Legal name
MedVoima Oy
Y-tunnus number
3126142-2
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
14. maaliskuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Terveyskeskus- ja vastaavat yleislääkäripalvelut.
Contact
Address
Sepelkyyhkyntie 3-C27
Phone
+358452666030
Email
handule.wali@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Espoo
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2024
Income statement
EUR thousands
Item
2021
2024
Revenue
48
0
Staff expenses
−40
−4
EBITDA
7
−21
Depreciation & amort.
—
−0
EBIT
7
−21
Net financials
—
−0
Profit before tax
7
−21
Tax
2
−0
Net profit
6
−21
Balance sheet
EUR thousands
Item
2021
2024
Total assets
16
9
Equity
6
8
Long-term debt
—
0
Short-term debt
10
1
Total debt
10
1
Financial ratios
5-year trend
EBITDA margin
-2058200.0%
This company
15.8%
Market median
-13026682% vs market
2021
2024
Equity ratio
84.7%
This company
38.2%
Market median
+122% vs market
2021
2024
Return on equity
-263.6%
This company
18.4%
Market median
-1533% vs market
2021
2024
Net profit margin
-2094400.0%
This company
8.1%
Market median
-25856890% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
WA
Wali Ali Handule
Chief Executive Officer
Chief Executive Officer
2020
Former (1)
FF
Farah Faarah Arab
Deputy Member
Deputy Member
2020 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MedVoima Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Farah Faarah Arab
Deputy Member
0 companies
Wali Ali Handule
Chief Executive Officer
0 companies